Sales and Marketing
Bayer buys out US-based Asklepios BioPharmaceutical in potential $4bn deal
October 26, 2020 Sales and Marketing Asklepios, Bayer, acquisition, pharma
AstraZeneca’s COVID-19 vaccine generates immune response in both old and young participants
October 26, 2020 Research and Development, Sales and Marketing AstraZeneca, COVID-19, University of Oxford, Vaccine
Novartis announces positive Phase 2 data of rare renal disease therapy iptacopan
October 26, 2020 Sales and Marketing
UK Government outlines steps to tackle growing misuse of fentanyl
October 26, 2020 Sales and Marketing
WHO warns regulators to consider all available evidence before approving remdesivir for COVID-19
October 26, 2020 Sales and Marketing COVID, COVID-19, Gilead, coronavirus
Patient Experience: Living with Timothy syndrome
October 26, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Timoty syndrome, feature, patient experience, rare disease
FDA approves Gilead’s remdesivir for hospitalised COVID-19 patients
October 23, 2020 Medical Communications, Sales and Marketing COVID-19, FDA, Gilead, remdesivir
Bayer’s Nubeqa secures NICE recommendation for hormone-relapsed prostate cancer at risk of metastasis
October 23, 2020 Medical Communications, Sales and Marketing Bayer, NCIE, Nubeqa, pharma
NICE recommends MSD’s Keytruda for untreated metastatic or unresectable recurrent head and neck squamous cell carcinoma
October 22, 2020 Sales and Marketing MSD, NCIE, NHS, keytruda
FDA grants priority review to AstraZeneca’s Tagrisso as an adjuvant for early-stage EGFR-mutated non-small cell lung cancer
October 20, 2020 Manufacturing and Production, Sales and Marketing AstraZeneca, FDA, Tagrisso
EMA’s CHMP recommends conditional approval for Kite Pharma’s CAR T therapy for mantle cell lymphoma
October 20, 2020 Manufacturing and Production, Sales and Marketing CAR T, CAR-T, CHMP, EMA, kite pharma, lymphoma
European Commission stands by €1bn remdesivir supply deal despite disappointing COVID-19 benefit
October 19, 2020 Manufacturing and Production, Sales and Marketing COVID-19, Europe, Gilead, remdesivir
Pfizer won’t apply for COVID-19 vaccine emergency authorisation until after US election, CEO says
October 19, 2020 Sales and Marketing COVID-19, Pfizer, US, Vaccine
UK life sciences industry does not want no-deal Brexit, says ABPI Chief
October 19, 2020 Sales and Marketing ABPI, EU, UK, brexit, pharma
Sanofi’s Dupixent chalks up CHMP recommendation for paediatric severe atopic dermatitis
October 19, 2020 Sales and Marketing Dupixent, EMA, Sanofi, atopic dermatitis
Latest content
Recruitment experts hired in search for new CGT Catapult chief
Envirogen secures place on NHS Scotland reverse osmosis framework
